Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxypipamperone for major depressive disorder (Phase II)
CTR20182127Phase 2Completed
- Sponsor
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxypipamperone in major depressive disorder (MDD), sponsored by Zhejiang Huahai Pharmaceutical Co., Ltd.. Started Nov 2018; status: completed.
02
Drugs
hydroxypipamperone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20182127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182127.